NCT06348641

Brief Summary

The aim of this study is to investigate the effect of baby massage applied to babies with retinopathy of prematurity on the pain and comfort of the newborn. This was randomised-controlled study in the NICU at the Health Sciences University Bursa High Specialization Training and Research Hospital, Bursa, Turkey. The population of the study will consist of preterms hospitalized in the neonatal intensive care unit during the time period of the study. In the calculation of the sample size, the power level was 80% and the significance level was 5%. When the effect size was determined as 0.8 in the examination of the difference between the experimental and control groups in terms of the premature infant pain profile (PIPP) variable, it was determined by the statistical expert that the number of babies to be included in each group was 26 and 52 babies in total should be included in the study. Based on this, the study sample was determined as 60 preterm infants in 30 experimental and 30 control groups. Block randomization method will be applied in the randomization of the groups. Case report form, PIPP=Premature Infant Pain Scale and Premature Infant Comfort Scale (PBIQ) will be used to collect the study data. Patients included in the study will be examined by the same ophthalmologist. The infant massage to be applied before the examination will be applied by a single nurse=researcher. Video recordings will be taken before and during the ROP examination and evaluations will be made by two neonatal nurses other than the researcher. Infants will be massaged by the researcher in accordance with IAIM guidelines and massage techniques. Total massage time will be equal for each infant. The researcher has an IAIM infant massage certificate. Before starting the infant massage, jewelry will be removed and hands will be washed. In the study, leg and face massage will be applied among the massage techniques in the IAIM guidelines.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Apr 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2024

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 5, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

April 20, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2025

Completed
Last Updated

April 5, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

March 10, 2024

Last Update Submit

April 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain during examination for retinopathy of prematurity

    Reducing the premature baby pain scale score of the experimental group compared to the control group. It is suitable for term and preterm babies and is used to evaluate acute and procedural pain. Scoring ranges from 0 to 21, with a score of six or lower being considered as no or minimal pain, between 7-12 points as moderate pain, and between 13-21 points as severe pain. It is evaluated 15 seconds before the intervention and 30 seconds after the intervention.

    Before, during and after ROP examination

Secondary Outcomes (1)

  • Comfort during retinopathy of prematurity examination

    Before, during and after ROP examination

Study Arms (2)

experimental group

EXPERIMENTAL

Babies in intervention classes will receive baby massage before the examination. Pre-examination baby massage will be applied by a single nurse = researcher. Video recording will be taken before and during the ROP examination, and evaluations will be made by two neonatal nurses other than the researcher. Babies will be massaged by the researcher in accordance with IAIM rules and massage techniques. The total massage time will be equal for each baby.

Other: baby massage

control group

NO INTERVENTION

For the control group, the routine retinopathy examination of the unit will be performed without any intervention. Video recording will be taken before and during the ROP examination, and evaluations will be made by two neonatal nurses other than the researcher.

Interventions

The infant massage to be applied before the examination will be applied by a single nurse=researcher. Video recordings will be taken before and during the ROP examination and evaluations will be made by two neonatal nurses other than the researcher.

experimental group

Eligibility Criteria

Age1 Day - 40 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \<32 gestational age
  • Birth weight of \<1500g
  • Who were clinical stable
  • Baby's first eye examination
  • The baby's family has permission

You may not qualify if:

  • Infants with previous ROP examination
  • Lack of mechanical ventilator support
  • Major congenital anomaly
  • Intraventriculer bleeding
  • Receiving analgesic medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PainRetinopathy of Prematurity

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsRetinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: In the calculation of the sample size, the power level was 80% and the significance level was 5%. When the effect size was determined as 0.8 in the examination of the difference between the experimental and control groups in terms of the premature infant pain profile (PIPP) variable, it was determined by the statistical expert that the number of babies to be included in each group was 26 and 52 babies in total should be included in the study. Based on this, the study sample was determined as 60 preterm infants in 30 experimental and 30 control groups. Block randomization method will be applied in the randomization of the groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 10, 2024

First Posted

April 5, 2024

Study Start

April 20, 2024

Primary Completion

April 20, 2025

Study Completion

April 20, 2025

Last Updated

April 5, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share